Sopharma Trading ADXBUL:SFT +0.69%85 Forward Dividend Yield % is 0.00% as of Jul. 05, 2026. GuruFocus rates XBUL:SFT with a GF Score™ of 85/100 and a GF Value™ of €7.63 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 66 Medical Distribution companies, Sopharma Trading AD ranks worse than 1515150% on this metric.
As of today (2026-07-05), the Forward Annual Dividend Yield of Sopharma Trading AD is 0.00%.
As of today (2026-07-05), the Trailing Annual Dividend Yield of Sopharma Trading AD is 0.00%.
XBUL:SFT's Forward Dividend Yield % is not ranked *
in the Medical Distribution industry.
Industry Median: 2.81 * Ranked among companies with meaningful Forward Dividend Yield % only.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Sopharma Trading AD was 26.00% per year. The lowest was 0.00% per year. And the median was 9.40% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Sopharma Trading AD (XBUL:SFT) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Sopharma Trading AD Forward Dividend Yield % Related Terms
XBUL:SFT vs MCK, CAH, COR: Forward Dividend Yield % Comparison
For the Medical Distribution subindustry, Sopharma Trading AD's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma Trading AD Forward Dividend Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Sopharma Trading AD's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Sopharma Trading AD (XBUL:SFT) has a Forward Dividend Yield % of 0.00% as of Jul. 05, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Sopharma Trading AD and its competitors. According to the industry distribution chart, Sopharma Trading AD ranks #999999 out of 66 companies in the Medical Distribution industry.
Is Sopharma Trading AD's Forward Dividend Yield % too high?
Sopharma Trading AD's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Sopharma Trading AD ranks #999999 out of 66 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Sopharma Trading AD has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sopharma Trading AD's Forward Dividend Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sopharma Trading AD ranks #999999 out of 66 companies for Forward Dividend Yield %. This places Sopharma Trading AD in the lower half of its industry. The industry median Forward Dividend Yield % is 2.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Distribution company?
The median Forward Dividend Yield % among Medical Distribution companies is 2.81, based on 66 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Sopharma Trading AD and its competitors. For the Medical Distribution industry, the median Forward Dividend Yield % is 2.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sopharma Trading AD's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma Trading AD stock overvalued right now?
Based on GuruFocus' analysis, Sopharma Trading AD (XBUL:SFT) is currently considered Significantly Undervalued. The stock's GF Value™ is €7.63, compared to a current price of €2.92 — trading 61.7% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Sopharma Trading AD's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Sopharma Trading AD (XBUL:SFT), the current Forward Dividend Yield % is 0.00% as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sopharma Trading AD (XBUL:SFT) Overvalued in 2026?
Based on GuruFocus' analysis, Sopharma Trading AD stock appears to be undervalued.
The current stock price of €2.92 is trading 61.7% below its estimated GF Value™ of €7.63.
GuruFocus considers Sopharma Trading AD to be Significantly Undervalued.
Key valuation signals for XBUL:SFT:
Forward Dividend Yield %: 0.00%
GF Value™: €7.63 vs. price of €2.92 (61.7% below fair value)
No single metric tells the full story. See the XBUL:SFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
85GF Score
Get the complete analysis for XBUL:SFT
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XBUL:SFT has been successfully added to your 